<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="93892">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01651455</url>
  </required_header>
  <id_info>
    <org_study_id>MAESTRALE</org_study_id>
    <nct_id>NCT01651455</nct_id>
  </id_info>
  <brief_title>Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000</brief_title>
  <acronym>MAESTRALE</acronym>
  <official_title>Maintaining Lung Function in Cystic Fibrosis Patients: Evaluation and Comparison Between Two Decades in a Retrospective Monocentric Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chiesi Farmaceutici S.p.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medidata Solutions</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Chiesi Farmaceutici S.p.A.</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to describe two cohorts of cystic fibrosis patients treated in
      2 different decades in terms of FEV1 (Forced Expiratory Volume in one second) maintenance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to describe two cohorts of cystic fibrosis patients treated in
      terms of FEV1 maintenance from the age of 10 to 15 before and after 2000.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>To describe the difference in terms of FEV1 decline between two cohorts of cystic fibrosis patients</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>To identify clinical parameters or treatments correlated to FEV1 maintenance in two cohorts of cystic fibrosis patients</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To evaluate the number of patients with Pseudomonas Aeruginosa infection during observational period</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To describe length of time without Pseudomonas A. infection in non-colonized patients during observational period.</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">92</enrollment>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>Cohort first decade</arm_group_label>
    <description>Patients born between 01/01/1979 and 12/31/1984</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cohort second decade</arm_group_label>
    <description>Patients born between 01/01/1991 and 12/31/1996</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients affected with Pseudomonas A. living in the N-E area of Italy.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Cystic Fibrosis diagnosed with neo-natal screening

          -  Patients born between 01/01/1979 and 12/31/1984 (Cohort 1)and patients born between
             01/01/1991 and 12/31/1996 (Cohort 2)

          -  Patients with at least 2 FEV1 yearly measurements from the age of 10 to 15

        Exclusion Criteria:

          -  Patients with malignant tumor

          -  Patients with meconium ileus

          -  Patients with transplantation (pneumectomy or lobectomy)

          -  Patients involved in any other clinical trial

          -  Patients moved to another Clinical Center
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Baroukh Maurice Assael, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>U.O. Fibrosi Cistica Azienda Ospedaliera Verona</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>U.O. Azienda Ospedaliera</name>
      <address>
        <city>Verona</city>
        <state>Veneto</state>
        <zip>37126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 30, 2013</lastchanged_date>
  <firstreceived_date>July 25, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cystic Fibrosis</keyword>
  <keyword>Pseudomonas Aeruginosa</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
